OverviewChartNewsTraderScreen

LBBW Discount Zert ESL 02.01.2026/  DE000LB465D4  /

EUWAX
7/5/2024  9:09:49 AM Chg.+0.33 Bid10:00:42 PM Ask10:00:42 PM Underlying Strike price Expiration date Option type
156.46EUR +0.21% -
Bid Size: -		 -
Ask Size: -		 ESSILORLUXO. INH. EO... - - 1/2/2026 Call
TeleTrader 6/17 Europe markets open higher ahead of BoE decision
TeleTrader 5/7 Europe closes higher after data, earnings
TeleTrader 4/23 Meta adds WhatsApp, Messenger video calling on smart glasses
TeleTrader 4/19 Europe opens lower with Middle East in focus
GlobeNewswire 4/9 DIAGNOS inc. to Present at the AI & Technology Hybrid Investor Conference April 11th
TeleTrader 1/16 Europe opens lower amid economic data
TeleTrader 1/15 Europe closes lower after data
GlobeNewswire 11/15/2023 TuneIn Launches New Integration with HumanWare to Enhance Accessibility for the Visually Impaired Co...
TeleTrader 10/6/2023 Europe opens higher after data
TeleTrader 9/22/2023 Europe opens lower amid data
GlobeNewswire 9/7/2023 Institutional Investor Launches 2023 Developed Europe & Emerging Emea Executive Team Rankings
TeleTrader 5/31/2023 DAX falls 1.5% at close after US job market data
TeleTrader 4/21/2023 Europe closes higher following PMI reports
TeleTrader 4/21/2023 Europe opens mostly lower as earnings, data come in
TeleTrader 2/8/2023 European stocks rise as FTSE 100 hits new record high
TeleTrader 2/3/2023 Europe closes mostly up as business activity recovers
TeleTrader 1/20/2023 Europe closes with modest gains after volatile week
TeleTrader 10/4/2022 Europe closes higher in anticipation of ECB's accounts
TeleTrader 6/17/2022 Europe edges higher as investors await key inflation data
TeleTrader 5/19/2022 Europe opens lower on inflation concerns
TeleTrader 4/22/2022 Europe falls at open amid earnings, data
TeleTrader 4/14/2022 Europe closes higher after ECB, Lagarde's remarks
GlobeNewswire 3/17/2022 SightGlass Vision Joint Venture Begins Operation
TeleTrader 3/11/2022 Europe opens mostly higher, amid inflation, GDP data
GlobeNewswire 3/10/2022 NovaSight Announces Successful Results of Pivotal Amblyopia Treatment Trial